Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (66.7%)Phase 1
1 (33.3%)Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2)
- First Posted Date
- 2025-10-24
- Last Posted Date
- 2025-10-24
- Lead Sponsor
- NodThera Limited
- Target Recruit Count
- 80
- Registration Number
- NCT07220629
- Locations
- 🇺🇸
Investigative Site, Manassas, Virginia, United States
Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus
Not Applicable
Recruiting
- Conditions
- Obesity and Type 2 Diabetes
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-07-09
- Last Posted Date
- 2025-10-14
- Lead Sponsor
- NodThera Limited
- Target Recruit Count
- 162
- Registration Number
- NCT07055516
- Locations
- 🇺🇸
Investigative site, Cooper City, Florida, United States
🇺🇸Investigative Site, Manassas, Virginia, United States
🇺🇸Investigative Sites, Marrero, Louisiana, United States
Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- NodThera Limited
- Target Recruit Count
- 67
- Registration Number
- NCT06129409
- Locations
- 🇺🇸
Investigative Site, Austin, Texas, United States
News
No news found